Steven Casper, PhDDean of the School of Applied Life Sciences; Henry E. Riggs Professor of Management
Economic Sociology, International Business , Science and Technology Policy
Dr. Casper received his PhD in government from Cornell University. He came to KGI from the University of Cambridge, UK, where he was a University Lecturer in Innovation and Entrepreneurship at the Judge Institute of Management Studies. He was previously employed as a Senior Research Fellow at the Social Science Center, Berlin.
Dr. Casper is widely published in the fields of economic sociology, international business, and public policy. He has written a book on the development of the science-based industry in Europe (Creating Silicon Valley in Europe: Public Policy Towards New Technology Industries, Oxford University Press, 2007). Dr. Casper has been selected as an academic year fellow at the Netherlands Institute of Advanced Studies and a summer fellow at the Center for Advanced Study in the Behavioral Sciences, Stanford University. In 2009, Casper was awarded a Fulbright Research Scholarship to do research in Canada.
The course will equip students with an understanding of conceptual frameworks in market strategy and market assessment with reference to bioscience industries.
While the pharmaceutical industry has long been a global industry, most R&D took place in the United States and a few European economies and global activities primarily involved creating sales and regulatory affairs offices to serve national markets. In recent years, however, the globalization of world markets and the rapid development of sophisticated bioscience industries in India, China, and other emerging markets are creating a reorganization of the pharmaceutical and related bioscience industries. In this course will learn how to assess bioscience market opportunities within different regions of the world, including advanced economies in East Asia and Europe and rapidly emerging marketplaces such as China and India. We will also explore the causes and consequences of globalization, focusing on the increased ability of firms, both small and large, to develop global value chains that integrate research, development and other marketplace activities from regions around the world.
Despite tremendous advances in medical technology have occurred over the last few decades, many individuals face limited access to medicines. This course provides an introduction to global health policy, focusing particular attention on examining different public policy perspectives oriented towards creating drugs for neglected diseases. We will explore how the creation of global value chains has created opportunities to develop new and perhaps more effective policies to lessen the long-standing global health problems. We will also examine the role of pharmaceutical and biotechnology companies within global health policy initiatives, paying particular attention to market oriented policies and public-private partnerships. Finally, we will examine the role of social entrepreneurs in creating innovative solutions for global health problems.
Casper S. "Public Research Systems, Career Structures and the Commercialization of Academic Science in Different Capitalisms". In: Morgan G, Campbell J, Crouch C, et al., editors. Handbook of Comparative Institutional Analysis. Oxford University Press; 2011
Casper S. "Institutional Frameworks and Public Policy Towards Biotechnology: Can Asia Learn from Europe?" Asian Business & Management 2009;8:363-395
Casper S. "Can New Technology Firms Succeed in Coordinated Market Economies? A Response to Herrmann and Lange". Socio-Economic Review 2009 Apr 1;7(2):209-215
Casper S. Creating Silicon Valley in Europe: Public Policy Towards New Technology Industries. illustrated ed. Oxford University Press; 2007
Casper S. "How Do Technology Clusters Emerge and Become Sustainable? Social Network Formation and Inter-firm Mobility within the San Diego Biotechnology Cluster". Research Policy 2007;36(4):438-455
Casper S. "Exporting Silicon Valley to Europe: How Useful is Comparative Institutional Theory?" In: Hage J, Meeus M, editors. Innovation, Science, and Institutional Change: A Research Handbook. Oxford: Oxford University Press; 2006
Casper S, Murray F. "Careers and Clusters: analyzing the career network dynamic of biotechnology clusters". Journal of Engineering and Technology Management 2005;22(1-2):51-74
Casper S, Murray F. "Examining the Marketplace for Ideas: How Local are Europe's Biotechnology Clusters". In: McKelvey M, Rickne A, Laage-Hellman J, editors. The Economic Dynamics of Biotechnology. Edward Elgar; 2004
Casper S, Whitley R. "Managing competences in entrepreneurial technology firms: a comparative institutional analysis of Germany, Sweden and the UK". Research Policy 2004;33(1):89-106
Casper S, Matraves C. "Institutional Frameworks and Innovation in the German and UK Pharmaceutical Industry". Research Policy 2003;32(10):1865-1879
Casper S, Karamanos A. "Commercializing Science in Europe: The Cambridge Biotechnology Cluster". European Planning Studies 2003;11(7):805-822
Casper S, Kettler H. "National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models within The German and UK Biotechnology Sectors". Industry and Innovation 2001;8(1):3-50
Casper S, Kettler H. "Turning Good Science into Successful Businesses: The Technology Transfer Systems in the UK and Germany". International Journal of Commercial Biotechnology 2001;7:197-207
Casper S. "Institutional adaptiveness, Technology Policy, and the Diffusion of New Business Models: The case of German Biotechnology". Organization Studies 2000;21(5):887-914
Dr. Casper's research explores how regional bioscience clusters emerge and become sustainable. His current project uses social network analysis to explore the history of the California biotechnology industry. He is also conducting cross-national comparative studies to investigate the effectiveness of different types of public policy in creating well-performing science-based industries. Dr. Casper's research interests include comparative studies of the development of new technology industries. Dr. Casper maintains a special interest in processes by which biomedical science has been commercialized across the U.S. and Europe.
Current Research Projects
Creating Successful Biotechnology Clusters: Dr. Casper is currently completing a book exploring how bioscience clusters emerged and became sustainable across different regions within California. He is also conducting ongoing cross-national research on whether public policy can be used to create biotechnology clusters. His current research in this area focuses on Canada, the United States, and Germany.
Cross-national Comparisons of Commercialization Processes: Universities vary tremendously in their ability to commercialize science and through doing so develop networks linking companies with university scientists. Dr. Casper's research in this area explores how the orientation of national research systems, specifically patterns of career competition across scientists, influence patterns by which science is commercialized. His research in this area compares the commercialization of biological science discoveries in the United States and Japan.
Future Research Interests
Dr. Casper's future research interests include public policy towards global health, particularly policies attempting to create new patterns of drug discovery towards neglected disease, and cross-national comparisons of how national research systems are organized, distinctively labor markets, and how this impacts commercialization processes.